Neurohypophyseal hormones and several of their analogs as well as N-terminal and C-terminal fragments, have been studied for their ability to attenuate puromycin-induced amnesia in mice. arginine]vasopressin, and the analogs des--0lycinamide{8-lysine]vasopressin, [1-p-mercaptopropionic acid, 8-lysinelvasopressin, [1,6-aminosuberic acid, 8-lysine vasopressin, [4-leu- Gly-NH2, as well as its derivatives D-Leu-Gly-NH2 and the diketopiperazine, cyclo(-Leu-Gly-).
Peptides possessing behavioral and electrophysiological activities are the focus of increasing attention (1) (2) (3) (4) (5) (6) (7) (8) (9) . Among these peptides are the antidiuretic hormone of pig, [8-ly- sine]vasopressin (LVP) (for primary structures see Fig. 1 ), and des-9-glycinamide-LVP (DGLVP), which was isolated from hog pituitary (6) . The peptides delay extinction of active avoidance behavior in intact rats (10) (11) (12) and restore the ability of hypophysectomized rats to acquire a conditioned avoidance response (3, 5) . Furthermore, rats with hereditary diabetes insipidus, which are unable to synthesize vasopressin (13) , fail to exhibit passive avoidance behavior (14) as do rats treated intracerebrally with antiserum to [8-arginine] vasopressin (AVP) (15) . These results, in conjunction with the dependence of LVP effects on the time of hormone administration (16) AVP acid, arginine vasopressinoic acid, [8-argininelvasopressinoic acid; DGLVP and DGOXY, des-9-glycinamide- [8-lysinelvasopress- in, des-9-glycinamide-oxytocin; DGDLOXY, des-9-glycinamide, des-8-leucine-oxytocin; AVT, arginine vasotocin, [8- arginineloxytocin; PLG, prolyl-leucyl-glycinamide; Asu, aminosuberic acid; cycle (-Leu-Gly-), the diketopiperazine of Leu-Gly; Mpr, fl-mercaptopropionic acid; Boc, tert-butyloxycarbonyl; Z, benzyloxycarbonyl; Bzl, benzyl; Sar, sarcosine.
AVP affect consolidation of some aspect of the memory process (12, 15, 16) . Furthermore, while memory of mazelearning in mice is blocked for long periods by intracerebral injections of puromycin one or more days after training (17) , treatment with DGLVP markedly attenuates the puromycin-induced amnesia (18) .
In the present work we report on the protective effects of LVP and AVP on the amnestic action of puromycin in mice and on similar effects of several neurohypophyseal hormone analogs. The protective effects of DGLVP observed earlier using DGLVP obtained after tryptic digestion of LVP (18) have been confirmed with a preparation of DGLVP secured by direct synthesis; this approach excludes the possible contamination of DGLVP by LVP. In addition, we find that Pro-Leu-Gly-NH2 (PLG), which is formed by hypothalamic enzyme(s) from oxytocin (19, 20) and which was isolated from ox hypothalamus (21) , attenuates the puromycin-induced blockade of memory. The structure-activity relationship study stimulated by these results indicates that certain derivatives of PLG such as Z-PLG and Leu-Gly-NH2 are even more active than PLG itself. Tentative deductions have been made regarding the structural requirements of these various groups of peptides for their effects on memory.
MATERIALS AND METHODS
LVP, AVP, oxytocin, PLG, Z-Pro-Leu-Gly-NH2, Leu-Gly-NH2-AcOH, Z-Leu-Gly-NH2, D-Leu-Gly-NH2, and thyrotropin releasing hormone (<Glu-His-Pro-NH2) were from the same batches used in earlier studies (19, 22) , as were ProLys-Gly-NH2, <Glu-Leu-Gly-NH2 (22) (28) , and the diketopiperazine of Leu-Gly (29) .
[Tri-Gly]LVP (30) Behavioral Training and Testing. The behavioral techniques have been fully described (36) . Swiss-Webster mice (6-7 months old, 30-35 g) from our inbred colony were trained in a single session in a Y-maze to a criterion of nine out of 10 correct responses. Intermittent foot shock, manually applied (0.2-0.4 mA from a dc source; 2 sec on, 2 sec off) was given for failure to move from the stem of the Y within 5 sec and for errors of left-right discrimination. Shock was adjusted with individual mice to the minimal level consistent with the desired behavioral response. The same procedure was used in tests, given 1 week after treatment with puromycin, for retention of memory of the training experience. A final test of retention of relearning was given 1-2 weeks after the first retention test. Mice which scored poorly on this final retention test were discarded.
Total errors were the sum of latencies greater than 5 sec and of incorrect choices, i.e., all mistakes were added until, in 10 consecutive runs in the maze, the mouse had performed correctly in nine of them. Memory was evaluated in the retention tests in terms of the percentage savings of errors. These percentages were calculated by subtracting the number of errors to criterion in the retention tests from the number to criterion in training, dividing by the number in training and multiplying by 100. Savings of 100% indicate perfect memory; zero savings, complete loss of memory. The Mann-Whitney U test, one-tailed, was used for determining statistical significance. Injection of Puromycin and Peptides. Intracerebral injections of puromycin were bitemporal and were given 24 hr after training as described (36) . Each injection site received 90,g of puromycin-2 HCI (neutralized with NaOH) in 12 gl of water. As judged by their inhibition of protein synthesis, these bitemporal injections primarily affect the hippocampi and entorhinal cortices (37) . Peptides used in this study were Cys-Tyr -Phe -Gln -Asn -Cys-Pro-irg -Gly-NH2 As may have been expected on the basis of structural likenesses (Fig. 1) , AVP is similar to LVP in its effects on memory retention (Fig. 2) These results suggest that the features which distinguish vasopressins from oxytocin, i.e., the presence of the aromatic residue in position 3 of the 20-membered covalent ring in combination with a basic residue in position 8, and the influence of these features on the overall hormone conformation, are important for detectable attenuation of puromycin-induced amnesia in mice. The lack of activity of [Ala2]AVP and AVP acid indicates that other structural modifications can, nevertheless, strongly influence these basic requirements. For the most part these tentative conclusions are in line with those proposed by de Wied and coworkers (44) using a different behavioral test system.
A striking dissociation for DGLVP of endocrine effects and activity in memory retention is found upon comparison of biological activities of synthetic LVP and DGLVP (Table   1) . DGLVP is potent in protecting mice against amnestic effects of puromycin, while it has drastically reduced endocrine activities characteristic of neurohypophyseal hormones. This confirms the results of de Wied et al., who found similarly reduced endocrine activities for DGLVP in association with high activity in inducing resistance to extinction of active avoidance behavior (10) . The dissociation of behavioral and endocrine effects is also supported by results with [Leu4]LVP, which is effective in memory retention (Fig. 2) while exhibiting low agonistic or inhibitory endocrine activities (32) . An even more active LVP derivative in terms of memory retention is [tri-Gly]LVP (Fig. 2) , an analog with low specific endocrine activities but significantly prolonged duration of action (45, 46) . DDAVP and [tri-Glyloxytocin also possess high activity in memory retention. Apparently, the structural modification, i.e., elongation of the N-terminus with a tri-glycyl moiety, which has a tendency to enhance the inherent activity of LVP, also allows expression of activity undetectable in oxytocin per se. The protracted endocrinological actions of both DDAVP and [tri-Gly]LVP (45-47) may possibly result from slow enzymatic modification or from a change in hydrophobicity with a concomitant alteration in distribution patterns. Since Fig.   3 demonstrate the protective effects of C-terminal fragments of the neurohypophyseal hormones and analogs of these fragments. The C-terminal tripeptide of oxytocin, ProLeu-Gly-NH2, originally proposed to be the natural factor inhibiting the release of melanotropin (MSH) from the pituitary (19) , has more recently been found to possess extrapituitary central nervous system effects (e.g., 52-55). As shown in Fig. 3 , it is also active in attenuating puromycin-induced amnesia. Structure-activity studies on the MSH-release-inhibiting activity of PLG revealed that there are specific structural requirements for the N-and C-terminal residues of the tripeptide and that modifications of the side chain of the center residue are permitted (provided the L configuration is maintained) (22) . Similarly for memory-retention activity, Pro-Lys-Gly-NH2 is even more potent than PLG. ProIle-Gly-NH2 has greatly reduced and statistically nonsignificant, but still detectable effects. Varying the N-and C-terminal residues (i.e., <Glu-Leu-Gly-NH2 and Pro-Leu-SarAcOH) eliminates (Fig. 3) . It is not clear at present whether the biological effect of the C-terminal peptides is elicited by the same mechanisms as that of the neurohypophyseal hormones. Notably, larger molar doses of the C-terminal peptides than of the hormones have been used in this study.
In earlier studies using DGLVP (18) , the possibility that this peptide might alter the cellular interactions of puromycin rather than processes concerned with memory was shown to be untenable. We tentatively assume that the same holds true for the compounds found here to attenuate puromycin-induced amnesia. It will be of value to determine both the dose range over which the hormones, analogs, and fragments are active, as well as to study the effect of variations in time of injection relative to time of training, particularly with the "long-acting" hormone analogs. Moreover (59) . At this time the results presented here appear to be best explained by suppos- ing that the active compounds modify consolidation of memory in such a way that expression or retrieval of memory becomes insensitive to puromycin, and that there are distinct structural requirements if the peptides are to be active in this way. 
